Evidence map›Paper›PMID 41743630›Full record

ArticleCancer communications (London, England)2026

Hye Jeong Yun, Chan Ho Park, Dahye Yun, Hye-Ri Shin, Jeong Dong Lee, Changhee Park, Kiyeon Kim, Heejun Shim, Hyejin Sim, Se Min Kim and 10 more

Abstract read
In one paragraph

Article in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Hye Jeong YunCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Chan Ho ParkDepartment of Bioinformatics, Soongsil University, Seoul, Korea.
Dahye YunCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Hye-Ri ShinDepartment of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Jeong Dong LeeCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Changhee ParkDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Kiyeon KimDepartment of Bioinformatics, Soongsil University, Seoul, Korea.
Heejun ShimDepartment of Bioinformatics, Soongsil University, Seoul, Korea.
Hyejin SimCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Se Min KimCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Min Jung KimDepartment of Surgery, Seoul National University Hospital, Seoul, Korea.
Ji Won ParkDepartment of Surgery, Seoul National University Hospital, Seoul, Korea.
Seung-Bum RyooDepartment of Surgery, Seoul National University Hospital, Seoul, Korea.
Yoojoo LimLunit Inc., Seoul, Korea.
Seung-Yong JeongDepartment of Surgery, Seoul National University Hospital, Seoul, Korea.
Kyu Joo ParkDepartment of Surgery, Seoul National University Hospital, Seoul, Korea.
Tae-You KimCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Junil KimDepartment of Bioinformatics, Soongsil University, Seoul, Korea.ORCID https://orcid.org/0000-0002-1202-1808
Jae-Kyung WonDepartment of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Sae-Won HanCancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-3275-431X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CCAAT-Enhancer-Binding Protein-betaColorectal NeoplasmsCTLA-4 AntigenT-LymphocytesTumor EscapeAnimalsCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansImmunoediting, CancerLymphocytes, Tumor-InfiltratingMaleMiceTumor MicroenvironmentTumor Suppressor Protein p53CCAAT-Enhancer-Binding Protein-betaCEBPB protein, humanCebpb protein, mouseCTLA-4 AntigenCTLA4 protein, humanCtla4 protein, mouseTumor Suppressor Protein p53

Identifiers

PMID41743630
PMCPMC12929812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.